Track market-moving stories before they get noisy

The MemeCore price prediction outlook has changed dramatically over the past few weeks. Once viewed as one of the most visible projects in the meme sector, MemeCore suffered a devastating collapse that erased more than $3 billion in market value and forced analysts to completely reassess future expectations.

At the same time, a different trend is emerging. Investors who previously focused on traditional memecoins are increasingly exploring AI-powered memecoins that combine community engagement with practical utility.

This shift is reshaping the meme space and creating new opportunities for projects built around participation rather than speculation alone.

MemeCore Price Prediction Turns Defensive After Historic Collapse The latest MemeCore price prediction models are far less optimistic than earlier forecasts.

Following the token’s 84% crash, analysts have lowered expectations significantly. Most short-term projections now place MemeCore inside a consolidation range between $0.50 and $0.69 as the market attempts to establish a new baseline. While this range suggests the possibility of stabilization, it also reflects the uncertainty surrounding the project’s future.

The challenge facing MemeCore is not simply price recovery.

The collapse damaged investor confidence and exposed structural weaknesses that existed long before the selloff began. Recovering from that kind of reputational damage is often more difficult than recovering from a temporary market correction.

For this reason, many analysts believe the next phase for MemeCore will focus on rebuilding trust rather than chasing aggressive upside targets.

Why MemeCore’s Supply Structure Remains a Concern A major reason the MemeCore price prediction remains cautious is token concentration.

Blockchain data shows that the four largest wallets control more than 67% of the circulating supply. Such concentration creates a difficult environment for sustainable price appreciation because large holders have the ability to introduce significant selling pressure at any time.

This concern becomes even more important when combined with the recent collapse.

Many early holders remain deeply underwater. If prices recover modestly, some investors may view rallies as opportunities to exit positions rather than continue holding. That dynamic could limit the strength of future recoveries.

Without meaningful structural changes such as lockups, supply reductions, or improved distribution, analysts believe every relief rally may face substantial resistance.

The Meme Sector Is Changing The broader meme market is evolving beyond simple speculation.

For years, success depended largely on community enthusiasm and viral attention. While those factors still matter, investors increasingly want additional utility and participation mechanisms.

This shift is creating space for new types of projects.

Rather than relying solely on meme culture, emerging ecosystems are blending social engagement with artificial intelligence, prediction markets, automated tools, and reward systems. These features create recurring activity that extends beyond token trading.

As a result, capital is gradually rotating toward projects that can generate ongoing ecosystem participation.

How MemeToro Is Positioning Itself Differently One project benefiting from this transition is MemeToro ($MT).

Instead of operating as a traditional memecoin, MemeToro functions as a SocialFi ecosystem built around behavioral finance and AI-powered participation. The platform is designed to keep users engaged through multiple products rather than relying on a single narrative.

Its ecosystem includes AI-assisted memecoin creation, decentralized prediction markets, staking infrastructure, and Web3 entertainment features. Each component contributes to broader platform activity while creating utility for the native $MT token.

This multi-product approach stands in sharp contrast to many legacy meme projects that depend almost entirely on speculative demand.

Inside the MemeToro Utility Platform MemeToro’s presale architecture focuses on continuous participation. Users can create memecoins through an automated deployment system, allowing communities to launch assets without technical barriers. The ecosystem also includes prediction markets where participants can use $MT and BNB to forecast outcomes across crypto, sports, entertainment, and current events.

The platform further supports long-term engagement through staking rewards of up to 35% APR.

Alongside these products, the project’s roadmap includes automated sentiment tracking systems and plans for a dedicated blockchain designed to support the broader ecosystem. These initiatives aim to create utility that extends beyond meme culture alone.

Technical Specifications: $MT Distribution & Staking Metrics Review the formal allocation architecture, audit verification data, and release timelines designed for the sustainable expansion of the MemeToro ecosystem. The verified contract address is 0x44412181b….a8cfff.

The distribution framework splits the 1.2 billion total supply into clear structural pools. The public sale accounts for 71% of the tokens.

The remaining supply is divided into centralized exchange reserves at 10%, marketing partners at 7.56%, platform trading liquidity at 5%, network rewards at 4.44%, and the core team allocation at 2%.

More Information on MemeToro ($MT) Presale Here:

Website: https://memetoro.com/

X: https://x.com/memetoro_mt

Telegram: https://t.me/memetoro_mt

Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data!

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?

Let's take a look at what these Wall Street heavyweights have to say about GE Aerospace (GE - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

GE currently has an average brokerage recommendation (ABR) of 1.45, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 22 brokerage firms. An ABR of 1.45 approximates between Strong Buy and Buy.

Of the 22 recommendations that derive the current ABR, 17 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 77.3% and 9.1% of all recommendations.

Brokerage Recommendation Trends for GE

Check price target & stock forecast for GE here>>>

The ABR suggests buying GE, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Is GE Worth Investing In?In terms of earnings estimate revisions for GE, the Zacks Consensus Estimate for the current year has increased 0.1% over the past month to $7.48.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for GE. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for GE may serve as a useful guide for investors.

Paypal (PYPL - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this technology platform and digital payments company have returned -4.7%, compared to the Zacks S&P 500 composite's -1.4% change. During this period, the Zacks Financial Transaction Services industry, which Paypal falls in, has lost 1.5%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Paypal is expected to post earnings of $1.28 per share for the current quarter, representing a year-over-year change of -8.6%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of $5.3 points to a change of -0.2% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $5.78 indicates a change of +9.1% from what Paypal is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Paypal.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Paypal, the consensus sales estimate for the current quarter of $8.5 billion indicates a year-over-year change of +2.6%. For the current and next fiscal years, $34.26 billion and $35.71 billion estimates indicate +3.3% and +4.2% changes, respectively.

Last Reported Results and Surprise HistoryPaypal reported revenues of $8.35 billion in the last reported quarter, representing a year-over-year change of +7.2%. EPS of $1.34 for the same period compares with $1.33 a year ago.

Compared to the Zacks Consensus Estimate of $8.11 billion, the reported revenues represent a surprise of +2.96%. The EPS surprise was +5.51%.

Over the last four quarters, Paypal surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Paypal is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Paypal. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Intel (INTC - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the past month, shares of this world's largest chipmaker have returned +9.9%, compared to the Zacks S&P 500 composite's -1.4% change. During this period, the Zacks Semiconductor - General industry, which Intel falls in, has lost 6.5%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Intel is expected to post earnings of $0.21 per share for the current quarter, representing a year-over-year change of +310%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

The consensus earnings estimate of $1.06 for the current fiscal year indicates a year-over-year change of +152.4%. This estimate has changed +0.1% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $1.45 indicates a change of +36.8% from what Intel is expected to report a year ago. Over the past month, the estimate has changed +0.6%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Intel is rated Zacks Rank #1 (Strong Buy).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Intel, the consensus sales estimate of $14.39 billion for the current quarter points to a year-over-year change of +11.9%. The $58.07 billion and $63.73 billion estimates for the current and next fiscal years indicate changes of +9.9% and +9.7%, respectively.

Last Reported Results and Surprise HistoryIntel reported revenues of $13.58 billion in the last reported quarter, representing a year-over-year change of +7.2%. EPS of $0.29 for the same period compares with $0.13 a year ago.

Compared to the Zacks Consensus Estimate of $12.33 billion, the reported revenues represent a surprise of +10.09%. The EPS surprise was +2800%.

Over the last four quarters, Intel surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Intel is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Intel. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.

Pfizer (PFE - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this drugmaker have returned -9.5%, compared to the Zacks S&P 500 composite's -1.4% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has gained 4.7%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Pfizer is expected to post earnings of $0.68 per share for the current quarter, representing a year-over-year change of -12.8%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of $2.99 points to a change of -7.1% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $2.86 indicates a change of -4.3% from what Pfizer is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Pfizer.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Pfizer, the consensus sales estimate for the current quarter of $14.4 billion indicates a year-over-year change of -1.7%. For the current and next fiscal years, $61.64 billion and $59.75 billion estimates indicate -1.5% and -3.1% changes, respectively.

Last Reported Results and Surprise HistoryPfizer reported revenues of $14.45 billion in the last reported quarter, representing a year-over-year change of +5.4%. EPS of $0.75 for the same period compares with $0.92 a year ago.

Compared to the Zacks Consensus Estimate of $13.82 billion, the reported revenues represent a surprise of +4.56%. The EPS surprise was +5.63%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Pfizer is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Pfizer. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

© Andrew Angelov / Shutterstock.com

Washington is pouring real money into quantum, and the Q1 2026 reports from IonQ (NYSE:IONQ | IONQ Price Prediction) and IBM (NYSE:IBM) show why that matters. IonQ posted $64.67 million in revenue, up 755% year over year. IBM delivered $15.92 billion, up 9.46%. Same tailwind, two completely different financial realities.

Hypergrowth on Borrowed Time vs. Cash Machine on Cruise Control IonQ’s quarter looks dazzling on the top line. CEO Niccolo de Masi called it “the biggest quarter in our company’s history” and raised full-year guidance to $260 million to $270 million. Wins include the first 256-qubit sale to the University of Cambridge, DARPA’s HARQ selection, a $39 million Space Development Agency HALO contract, and an MDA SHIELD slot. Underneath, the burn is real: an adjusted EBITDA loss of $96.75 million, operating cash flow of negative $151 million, and $128.52 million in stock-based comp diluting holders.

IBM’s quarter looked nothing like that. Arvind Krishna highlighted “broad-based revenue growth across our segments”, with Software up 11.3%, Infrastructure up 15.3%, and IBM Z mainframe revenue surging 51%. Free cash flow landed at $2.22 billion, and the dividend was lifted to $1.69, the 31st consecutive annual hike.

Lens IonQ IBM Q1 Revenue $64.7M $15.92B Operating Cash Flow -$151M +$5.17B Funding Source Equity offerings Self-funded One Begs Capital Markets. The Other Writes Its Own Checks. IonQ is racing to build a full-stack quantum supplier through the pending SkyWater deal and a pipeline of national network builds in Poland, Florida, and the U.S. Mid-Atlantic. That ambition is expensive. With $493.5 million in cash and a full-year EBITDA loss guided to $310 million to $330 million, IonQ remains structurally reliant on dilutive equity offerings.

IBM’s quantum lab rides shotgun on a $249 billion machine. The $12.5 billion generative AI book of business and mainframe refresh cycle bankroll the research without touching shareholders. Polymarket traders price only a 17% chance of Uncle Sam taking an IonQ equity stake this year, a reminder that government money typically flows as contracts.

The Next Test Is Liquidity I will be watching whether IonQ converts its $470 million in remaining performance obligations into actual cash before the next capital raise. For IBM, the question is whether Infrastructure can repeat its 15.8% segment margin while Consulting stays stuck at 4.0% growth. IonQ shares are down 15.78% in the past month, while IBM trades at a sober 21x forward earnings.

Why IBM Looks Like the More Durable Quantum Exposure For investors seeking quantum exposure without dependence on the equity issuance window, IBM offers the more self-funded profile. The 2.66% dividend, low 0.665 beta, and self-funded R&D let you wait out the quantum adoption curve. IonQ can still pay off for risk-tolerant traders chasing the $67.64 analyst target, but at 116x sales with a 3.18 beta, you are paying for perfection. I would change my view on IonQ once free cash flow turns.

, /PRNewswire/ -- MGM Resorts International (NYSE: MGM) ("MGM Resorts" or the "Company") will release its financial results for the second quarter 2026 after the market closes on Wednesday, July 29, 2026. MGM Resorts will host a conference call that day at 5:00 p.m. Eastern Time, which will include a brief discussion of the results followed by a question and answer session. In addition, supplemental slides will be posted prior to the start of the call on MGM's Investor Relations website at http://investors.mgmresorts.com. 

The call will be accessible via the Internet through http://investors.mgmresorts.com/events-and-presentations/ or by calling 1-888-317-6003 for domestic callers and 1-412-317-6061 for international callers. The conference call access code is 3854404.

A replay of the call will be available through August 5, 2026. The replay may be accessed by dialing 1-855-669-9658 or 1-412-317-0088. The replay access code is 6498752.

About MGM Resorts International 
MGM Resorts International (NYSE: MGM) is an S&P 500® global gaming and entertainment company with national and international destinations featuring best-in-class hotels and casinos, state-of-the-art meetings and conference spaces, incredible live and theatrical entertainment experiences, and an extensive array of restaurant, nightlife and retail offerings. MGM Resorts creates immersive, iconic experiences through its suite of Las Vegas-inspired brands. The MGM Resorts portfolio encompasses 30 unique hotel and gaming destinations globally, including some of the most recognizable resort brands in the industry. The Company's 50/50 venture, BetMGM, LLC, offers sports betting and online gaming in North America through market-leading brands, including BetMGM and partypoker, and the Company's subsidiary, LV Lion Holding Limited, offers sports betting and online gaming through market-leading brands in several jurisdictions throughout Europe and Brazil. The Company is currently pursuing targeted expansion in Asia through an integrated resort development in Japan. Through its Focused on What Matters philosophy, MGM Resorts commits to creating a more sustainable future, while striving to make a bigger difference in the lives of its employees, guests and in the communities where it operates. The global employees of MGM Resorts are proud of their company for being recognized as one of FORTUNE® Magazine's World's Most Admired Companies®. For more information, please visit us at www.mgmresorts.com. Please also connect with us @MGMResortsIntl on X as well as Facebook and Instagram.

MGM RESORTS CONTACTS

Investment Community:
SARAH ROGERS, Senior Vice President of Corporate Finance and Treasurer
[email protected]

HOWARD WANG, Vice President of Investor Relations
[email protected]

News Media:
BRIAN AHERN, Executive Director of Communications
[email protected]

SOURCE MGM Resorts International

Key Takeaways NEM's expansion through projects and strong free cash flow support shareholder returns.Kinross is advancing growth projects while reducing debt and boosting liquidity.Both NEM and KGC have outpaced the industry with rising earnings estimates. Newmont Corporation (NEM - Free Report) and Kinross Gold Corporation (KGC - Free Report) are two prominent players in the gold mining space with global operations and diversified portfolios. Although gold prices have seen a sharp correction from the record highs reached in January 2026, they remain at supportive levels. Against this backdrop, comparing these two major industry players is particularly relevant for investors seeking exposure to the precious metals sector.

A combination of geopolitical tensions, a weaker U.S. dollar, tariff-related uncertainty and concerns about the Federal Reserve’s independence had propelled bullion to an all-time high of nearly $5,600 per ounce in late January. Since then, gold has retreated significantly due to inflation concerns triggered by a surge in crude oil prices amid Middle East tensions, with prices falling to $4,500 per ounce around the end of May.

The decline has continued this month, with prices recently falling near $4,000 per ounce, marking their lowest level in nearly eight months. The latest weakness reflects growing expectations of interest rate hikes and a stronger U.S. dollar, even as inflation fears eased following an interim agreement between the United States and Iran. Meanwhile, in its most recent policy meeting, the Federal Reserve left interest rates unchanged, but signaled a potential rate increase before the year's end. Even after the steep correction, gold prices remain roughly 21% higher than a year ago.

Let’s dive deep and closely compare the fundamentals of these two mining giants to determine which one is a better investment now.

The Case for NewmontNewmont continues to invest in growth projects in a calculated manner. The company is pursuing several projects, including the Cadia Panel Caves and Tanami Expansion 2 in Australia. These projects should expand Newmont’s production capacity and extend mine life, driving revenues and profits.

In October 2025, NEM achieved a significant milestone at Ahafo North. It achieved commercial production at the project, which followed the first gold pour in September 2025. Ahafo North is expected to produce between 275,000 and 325,000 ounces of gold annually over an estimated mine life of 13 years. Output is expected to be 315,000 ounces this year, with a ramp-up to full capacity.

NEM recently received key regulatory approvals from the Province of British Columbia for its Red Chris Block Cave Project, marking a major milestone in the planned transformation of the Red Chris Mine from an open-pit operation to a large-scale block-cave mine. The approvals move the project closer to a final investment decision, which Newmont expects to make later this year.

Newmont has also divested non-core businesses as it shifts its strategic focus to Tier 1 assets.   The company generated $3.6 billion from its portfolio optimization actions in 2025. These funds will support Newmont’s capital allocation strategy, which focuses on reinforcing its balance sheet and delivering returns to its shareholders.

Newmont has a strong liquidity position and generates substantial cash flows, which allow it to fund its growth projects, meet short-term debt obligations and drive shareholder value. At the end of the first quarter of 2026, Newmont had robust liquidity of roughly $12.8 billion, including cash and cash equivalents of around $8.8 billion. Its free cash flow surged 161% year over year to a record $3.1 billion in the first quarter, led by an increase in net cash from operating activities. Net cash from operating activities amounted to $3.8 billion in the first quarter, up from $2 billion in the year-ago quarter.

NEM has distributed $3.4 billion to its shareholders through dividends and share repurchases in 2025. It has returned $2.7 billion to its shareholders since Feb. 19, 2026. Newmont has executed buybacks of $6 billion under the earlier authorized share repurchase programs, including $2.4 billion since the fourth-quarter 2025 earnings call. Its board has approved an additional $6 billion repurchase program. NEM offers a dividend yield of 1.1% at the current stock price. Its payout ratio is 12%.

Newmont also remains committed to deleveraging, reducing debt by roughly $3.4 billion in 2025. It reduced debt by an additional $42 million in the first quarter, resulting in a strong net cash position of $3.2 billion.

NEM, however, saw lower gold production for the first quarter, partly linked to its strategic divestment of non-core assets. NEM reported a roughly 16% year-over-year and 10% sequential decline in attributable gold production to 1.3 million ounces. Newmont expects second-quarter 2026 production to be below the first-quarter level.

 The company anticipates gold production at about 5.26 million ounces for 2026, indicating a year-over-year decline from 5.89 million ounces in 2025. NEM expects lower production from Penasquito and Cadia in 2026 due to the site transitions. It also sees lower-than-expected production from Nevada Gold Mines and Pueblo Viejo. These will be partly offset by contributions from the newly commissioned Ahafo North mine.

The Case for KinrossKinross has a strong production profile and boasts a promising pipeline of exploration and development projects. Its key development projects and exploration programs remain on track. These projects are expected to boost production and cash flow, and deliver significant value. The successful execution of these projects will position the company for a new wave of low-cost, long-life production.

KGC is progressing with the construction of three organic growth projects to expand its U.S. portfolio. This is aimed at extending mine life and cost optimization. The projects are Round Mountain Phase X and Bald Mountain Redbird 2 in Nevada, and the Kettle River–Curlew project in Washington. Together, the projects are expected to contribute significantly to Kinross’ U.S. production profile. They are expected to contribute 3 million ounces of life-of-mine production to KGC’s portfolio, adding grades and mine lives.

KGC has strong liquidity of $3.9 billion and generates substantial cash flows, which allows it to finance its development projects, pay down debt and drive shareholder value. Kinross reactivated its share buyback program in April 2025. It completed a $600 million share repurchase program as of Dec. 31, 2025. The Toronto Stock Exchange, in March, accepted the notice to renew its normal course issuer bid program. KGC repurchased shares worth roughly $250 million in the first quarter and $300 million this year through April 29.

KGC generated a record free cash flow of roughly $2.5 billion last year. It returned $752.4 million to its shareholders through dividends and buybacks in 2025. The company also logged attributable free cash flow of $837.5 million in the first quarter, marking the fourth straight quarter of record free cash flow. It ended the quarter with about $1.4 billion in net cash.

In 2025, the company repaid $700 million of debt. With $1.7 billion in available credit (as of March 31, 2026) and no debt maturities until 2033, Kinross is well-positioned to support growth while strengthening its balance sheet and delivering shareholder value.

KGC’s board has approved a 14% increase to its quarterly dividend, amounting to 16 cents per share on an annualized basis. Kinross is targeting to return 40% of its free cash flow through share buybacks and dividends in 2026. KGC offers a dividend yield of 0.7% at the current stock price. It has a payout ratio of 7% with a five-year annualized dividend growth rate of roughly 2.4%.

Despite these positives, KGC remains exposed to headwinds from higher production costs. Its attributable production cost of sales per gold equivalent ounce was $1,380 in the first quarter, up 33% from the prior-year quarter’s levels. The rise was partly due to higher royalty costs stemming from increased gold prices. It saw first-quarter attributable all-in-sustaining costs (AISC) — a critical cost metric for miners — of $1,732 per ounce, marking a 28% increase from the year-ago quarter.

Kinross expects AISC to be $1,730 per ounce (+/-5%) for 2026, indicating a year-over-year increase from $1,571 per ounce in 2025, partly due to inflationary impacts. AISC is expected to be adversely impacted by cost inflation from elevated crude oil prices.

Price Performance and Valuation of NEM & KGCNEM stock has rallied 68% in the past year, while KGC stock has gained 61.7% compared with the Zacks Mining – Gold industry’s increase of 41.5%.

Image Source: Zacks Investment Research

NEM is currently trading at a forward 12-month earnings multiple of 9.24. This represents a modest 1.8% premium when stacked up with the industry average of 9.08X.

Image Source: Zacks Investment Research

Kinross is trading at a discount to Newmont. The KGC stock is currently trading at a forward 12-month earnings multiple of 8.27, below its industry average.

Image Source: Zacks Investment Research

How Do Zacks Consensus Estimates Compare for NEM & KGC?The Zacks Consensus Estimate for NEM’s 2026 sales and EPS implies a year-over-year rise of 20.2% and 43.8%, respectively. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

The consensus estimate for KGC’s 2026 sales and EPS implies year-over-year growth of 33.2% and 58.2%, respectively. The EPS estimates for 2026 have been trending northward over the past 60 days.

Image Source: Zacks Investment Research

NEM or KGC: Which Stock is a Better Pick Now?NEM and KGC currently carry a Zacks Rank #3 (Hold) each, so picking one stock is not easy. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Both Newmont and Kinross are demonstrating strong financial performance and commitment to shareholder returns, supported by firm gold prices. Both have a strong pipeline of development projects and solid financial health. The companies are also seeing favorable estimate revisions. Kinross appears to have an edge over Newmont due to its more attractive valuation and higher growth projections. Investors seeking exposure to the gold space might consider KGC as the more favorable option at this time.

US SEC and CFTC Solicit Public Comments on Regulatory Framework for Portfolio Margin of Securities, Futures and Other Products

The U.S. Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) issued a joint announcement seeking public input on a coordinated regulatory framework for portfolio margin of securities, security-based swaps, futures, swaps, and related positions. The agencies are evaluating whether enhanced regulatory coordination will boost risk management efficiency, reduce market fragmentation, and strengthen customer protections. SEC Chair Paul Atkins noted that cross-margin mechanisms could unlock liquidity currently held in separate accounts. CFTC Chair Mike Selig added that deeper cooperation between the two agencies on portfolio margin could free up unused capital while ensuring a more robust risk management framework and market safeguards. The public comment period covers topics including current portfolio margin models and practices, customer protection considerations, cross-margin and cross-product hedging, capital, segregation, and collateral treatment, risk management methodologies, matters related to clearing agencies and derivatives clearing organizations, operational and technical implementation issues, and potential impacts on market liquidity and competition. The comment window is 60 days following publication in the Federal Register.

7 minutes ago

US SEC and CFTC Solicit Public Comments on Regulatory Framework for Portfolio Margins Covering Securities, Futures and Other Related Products

U.S. Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) issued a joint announcement seeking public comment on a coordinated regulatory framework for portfolio margin covering securities, security-based swaps, futures, swaps, and related positions. The agencies are evaluating whether enhanced inter-agency regulatory coordination will help improve risk management efficiency, reduce market fragmentation, and strengthen customer protection. SEC Chair Paul Atkins noted that cross-margin mechanisms could unlock liquidity currently held in separate accounts. CFTC Chair Mike Selig added that strengthened inter-agency cooperation on portfolio margin could free up unused capital while ensuring more robust risk management frameworks and market safeguards. The comment period covers topics including current portfolio margin models and practices, customer protection considerations, cross-margin and cross-product hedging, capital/segregation/collateral handling, risk management methodologies, matters related to clearinghouses and derivatives clearing organizations (DCOs), operational and technical implementation issues, and potential impacts on market liquidity and competition. The public comment window will remain open for 60 days following publication in the Federal Register.

7 minutes ago

US stock declines narrowed, S&P 500 index briefly turned positive.

According to Bitget market data, U.S. stock market losses narrowed, the S&P 500 index briefly turned positive, the Dow Jones Industrial Average edged down 0.01%, and the Nasdaq’s decline narrowed to 0.26%.

7 minutes ago

SemiAnalysis: Naura Technology accelerates the localization of China's etching sector, holding the leading market share in Changxin Memory's ICP etching market.

Independent semiconductor and AI research firm SemiAnalysis noted in a report that China’s localization process for etching equipment is accelerating, with progress clearly outpacing that of deposition equipment. Data shows that year-to-date, etching equipment imports among China’s front-end equipment have dropped 18% year-over-year, while deposition equipment imports have risen 3% year-over-year. SemiAnalysis believes this indicates that China’s domestic substitution in the etching sector has achieved substantial breakthroughs. Financial results from global etching leaders corroborate this judgment: Applied Materials’ China revenue fell 16% year-over-year in fiscal 2025, while Tokyo Electron’s China revenue dropped 18% year-over-year in fiscal 2026. SemiAnalysis points out that North Huachuang is a key driver of this trend; channel research shows it holds the leading share in the ICP etching market at ChangXin Memory. As ChangXin continues expanding production, North Huachuang is expected to further consolidate its market share and scale up its revenue.

7 minutes ago

Barclays cuts its 2026 Brent crude oil price forecast to $96 per barrel.

Barclays cuts its 2026 Brent crude oil price forecast to $96 per barrel, and its 2027 forecast to $85 per barrel.

7 minutes ago

At the opening of US stock markets, AI application software stocks rose against the trend, with ServiceNow and Figma climbing more than 5%.

According to Bitget market data, AI software stocks in the US market rose against the trend at opening. ServiceNow (NOW.US) and Figma Inc (FIG.US) jumped more than 5%, while Palantir (PLTR.US), Adobe (ADBE.US), Workday (WDAY.US), Salesforce (CRM.US), and Datadog (DDOG.US) gained over 3%, and Microsoft (MSFT.US) rose by more than 2%. Microsoft has hiked Xbox prices three times in 13 months, and stated that storage component costs will double next year.

7 minutes ago

The upcoming report from General Mills (GIS - Free Report) is expected to reveal quarterly earnings of $0.82 per share, indicating an increase of 10.8% compared to the year-ago period. Analysts forecast revenues of $4.6 billion, representing an increase of 1% year over year.

The consensus EPS estimate for the quarter has undergone a downward revision of 1.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

That said, let's delve into the average estimates of some General Mills metrics that Wall Street analysts commonly model and monitor.

Based on the collective assessment of analysts, 'Net Sales- North America Foodservice' should arrive at $581.13 million. The estimate suggests a change of +0.3% year over year.

Analysts predict that the 'Net Sales- International' will reach $840.10 million. The estimate suggests a change of +13.7% year over year.

The average prediction of analysts places 'Net Sales- North America Pet' at $717.24 million. The estimate suggests a change of +6.2% year over year.

Analysts expect 'Net Sales- North America Retail' to come in at $2.49 billion. The estimate points to a change of -2.9% from the year-ago quarter.

Analysts' assessment points toward 'Operating Profit- North America Retail' reaching $501.90 million. The estimate is in contrast to the year-ago figure of $473.80 million.

Analysts forecast 'Operating Profit- International' to reach $39.51 million. Compared to the present estimate, the company reported $33.70 million in the same quarter last year.

The consensus among analysts is that 'Operating Profit- North America Pet' will reach $144.19 million. Compared to the present estimate, the company reported $140.10 million in the same quarter last year.

The combined assessment of analysts suggests that 'Operating Profit- North America Foodservice' will likely reach $78.16 million. Compared to the present estimate, the company reported $83.10 million in the same quarter last year.

View all Key Company Metrics for General Mills here>>>

Shares of General Mills have demonstrated returns of +4.5% over the past month compared to the Zacks S&P 500 composite's -1.4% change. With a Zacks Rank #4 (Sell), GIS is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Snowflake Inc. (SNOW - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this company have returned -5.1%, compared to the Zacks S&P 500 composite's -1.4% change. During this period, the Zacks Internet - Software industry, which Snowflake falls in, has lost 7.4%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Snowflake is expected to post earnings of $0.45 per share, indicating a change of +28.6% from the year-ago quarter. The Zacks Consensus Estimate has changed +5.8% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $1.93 points to a change of +54.4% from the prior year. Over the last 30 days, this estimate has changed +13.1%.

For the next fiscal year, the consensus earnings estimate of $2.57 indicates a change of +33.2% from what Snowflake is expected to report a year ago. Over the past month, the estimate has changed +7.2%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Snowflake is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Snowflake, the consensus sales estimate for the current quarter of $1.47 billion indicates a year-over-year change of +28.4%. For the current and next fiscal years, $6.07 billion and $7.55 billion estimates indicate +29.6% and +24.4% changes, respectively.

Last Reported Results and Surprise HistorySnowflake reported revenues of $1.39 billion in the last reported quarter, representing a year-over-year change of +33.5%. EPS of $0.39 for the same period compares with $0.24 a year ago.

Compared to the Zacks Consensus Estimate of $1.32 billion, the reported revenues represent a surprise of +5.23%. The EPS surprise was +21.88%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Snowflake is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Snowflake. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Costco (COST - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Shares of this warehouse club operator have returned -5.3% over the past month versus the Zacks S&P 500 composite's -1.4% change. The Zacks Retail - Discount Stores industry, to which Costco belongs, has lost 4% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Costco is expected to post earnings of $6.49 per share, indicating a change of +10.6% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.1% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $20.38 points to a change of +13.3% from the prior year. Over the last 30 days, this estimate has changed +0.3%.

For the next fiscal year, the consensus earnings estimate of $22.46 indicates a change of +10.2% from what Costco is expected to report a year ago. Over the past month, the estimate has changed +0.3%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Costco is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Costco, the consensus sales estimate of $93.85 billion for the current quarter points to a year-over-year change of +8.9%. The $301.03 billion and $324.4 billion estimates for the current and next fiscal years indicate changes of +9.4% and +7.8%, respectively.

Last Reported Results and Surprise HistoryCostco reported revenues of $70.53 billion in the last reported quarter, representing a year-over-year change of +11.6%. EPS of $4.93 for the same period compares with $4.28 a year ago.

Compared to the Zacks Consensus Estimate of $69.5 billion, the reported revenues represent a surprise of +1.47%. The EPS surprise was +0.41%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Costco is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Costco. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Lemonade (LMND +0.07%) has become a popular insurance technology company over the past few years. Insurance is an industry full of legacy players, with some giants that are more than a century old, and it was ripe for disruption with the advent of artificial intelligence (AI).

Although it got off to a bumpy start, losing more than 90% of its value at one point, Lemonade stock has made a sustained comeback, up 247% over the past three years. Can it do a repeat performance?

Sweetening the deal Lemonade is a digital insurance company that relies on AI and machine learning to price policies, onboard customers, and approve claims. This removes human intervention as much as possible, making for a simpler, quicker, and more transparent experience. At some point, it should be cheaper to operate as well.

For now, it's adding customers at a rapid pace, including a 23% year-over-year increase in the 2026 first quarter to over 3 million in total; that's double the count from 2022.

Image source: Getty Images.

In-force premium (IFP), the standard top-line metric for insurance companies, has accelerated over the past 10 quarters, rising 32% year over year in the first quarter, while gross margin improved from 26% to 39%.

The main reason the stock bounced back and has performed so well over the past few years is the improvement in its loss ratio. That measures how much Lemonade pays out in claims, and it's been trending down. At 62% in the first quarter, it's well within the target range and comparable to other insurance companies.

Management believes it has an edge over legacy companies because its digital parts are interconnected and work together. The larger, older companies are all moving toward this model, but even though Lemonade is younger, it has a head start here. Here, being smaller also works in its favor, since it's more agile and can make changes more easily.

What happens next Right now, Lemonade is still in rollout mode, and it has high expenses. That's eating into its profits, and it's still reporting losses even on an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) basis.

Today's Change

(

0.07

%) $

0.04

Current Price

$

56.03

Management is guiding for positive adjusted EBITDA by the end of this year and positive net income next year. From there, it envisions becoming much more profitable as AI and machine learning do their work.

So can Lemonade stock triple over the next three years? It trades at a price-to-sales ratio of 6, which is fair considering its growth. Revenue increased 71% in the first quarter, also an acceleration, so let's choose 50% as a possible compound annual growth rate (CAGR). In that case, trailing-12-month revenue would reach $2.4 billion from $725 million today, and keeping the price-to-sales ratio constant, the stock would indeed triple.

This is just one scenario. Revenue growth could decelerate further, and the price-to-sales ratio could go down. But as it becomes profitable, it's possible the stock could triple over the next three years.

Microsoft is the outlier here. It looks like it’s going to bounce a bit, but quite frankly, it’s been a straight line down for the entire month. Sooner or later, a bounce makes sense. When looked at through the prism of the longer term, we are pretty close to a major support region, right around $350. So we’ll see if this holds. If it doesn’t, we could see this market drop down to the $315 level pretty quickly.

To the upside, I have a hard time believing we’re going to clear 375 easily. This might be a short-term “smash and grab” type of trade on the upside, but to have a longer-term bottom, we need to put in more work. This has been a complete crash down from the beginning of June, dropping directly from $466, losing $110 a share pretty quickly. That obviously is a big deal. If they can get some type of bounce here, it’s a good short-term trade. Longer-term trade, they need to work out their issues with Copilot not being adopted.

HIVE Digital Technologies Ltd (TSX:HIVE, NASDAQ:HIVE, FRA:YO0, BVC:HIVECO) has announced the pricing of an upsized private offering of $115 million in zero-coupon exchangeable senior notes due 2031, increasing the size of the deal from the previously announced $100 million.

The notes will be issued by HIVE Bermuda 2026 Ltd., a wholly owned subsidiary of HIVE, and are expected to close on June 30, subject to customary conditions. Initial purchasers have also been granted an option to buy up to an additional $15 million of notes within 13 days of issuance.

The notes will not pay regular interest and will mature on July 1, 2031, unless they are earlier exchanged, redeemed, or repurchased. They are exchangeable into cash, HIVE common shares, or a combination of both at the issuer's election. The initial exchange price is approximately $4.83 per share, representing a 27.5% premium to HIVE's Nasdaq closing price of $3.79 on June 25.

HIVE estimates net proceeds from the offering will total about $110 million, or roughly $124.5 million if the additional purchase option is exercised in full.

The company plans to use the funds for general corporate purposes, capital investments, including graphics processing unit (GPU) purchases, and data center development.

In connection with the offering, HIVE entered into cash-settled capped call transactions with certain financial institutions. The capped calls have an initial cap price of $8.53 per share, equal to a 125% premium over the June 25 closing price.

The company said the transactions are intended to reduce potential dilution from future exchanges of the notes and offset certain cash payments that could otherwise be required.

The notes are unsecured obligations of the issuer and are fully guaranteed by HIVE on a senior unsecured basis. Holders will have the right to require the issuer to repurchase their notes for cash on July 1, 2030, and under certain circumstances involving a fundamental change at the company.

The offering is being conducted as a private placement to qualified institutional buyers under Rule 144A of the US Securities Act.

Decentralized AI Exposure To Get Easier?Silbert promoted the launch of the Total Market Fund by Yuma, a DCG subsidiary, that provides a single allocation for exposure to TAO and tokens tied to AI projects built on Bittensor. The fund is marketed as an institutional gateway to decentralized AI infrastructure, offering exposure beyond traditional equities and venture capital.

“AI is becoming a core portfolio allocation. But for most investors, it’s limited to a few, big players,” Silbert noted. “Bittensor offers access to a decentralized network of AI projects.”

What’s Bittensor Moat?Bittensor is an open-source network that allows AI models to be shared, trained, and ranked by value. Participation and contribution are incentivized by handing out rewards in the form of the native cryptocurrency called TAO.

Silbert himself has picked Bittensor as one of the top projects where the majority of cryptocurrency capital is expected to rotate into eventually.

Silbert Bullish On Privacy NarrativeSilbert has also championed financial privacy, positioning privacy-focused coins as the cryptocurrency industry’s next major investment opportunity.

His thesis is that 5-10% of Bitcoin market cap would eventually rotate into privacy coins, including Zcash (CRYPTO: ZEC).

Price Action: At the time of writing, TAO was exchanging hands at $213.40, down 3.48% over the last 24 hours, according to data from Benzinga Pro, valued at over $2.35 billion.

Photo courtesy: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Stock News Global tech stocks tumble on AI spending and IPO delay: Major indices and tech shares, including Apple (AAPL), Alphabet (GOOGL), Microsoft (MSFT), an

5.08K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Micron Technology's MU shares fell sharply on Friday, giving up part of the gains recorded earlier in the week despite the memory chipmaker reporting stronger-than-expected quarterly results.

The stock declined nearly 5% in premarket trading as weakness spread across the broader semiconductor sector.

Other US chipmakers also traded lower, with Intel down just over 3%, Sandisk falling 5%, Arm shedding 4%, and Marvell declining 3.7%.

The decline came as investors remained cautious about the rising costs associated with artificial intelligence infrastructure, triggering a broader sell-off across global semiconductor stocks.

The weakness extended beyond the United States.

In Europe, ASML fell 2.2%, Infineon declined 3.7%, ASM International lost 2.8%, ST Microelectronics dropped 3.3%, and Be Semiconductor slipped 2%.

In Asia, Japanese conglomerate SoftBank led regional losses, plunging more than 12%.

The broader pullback followed a strong rally in AI-related semiconductor companies, even as Micron delivered robust financial results and issued an optimistic outlook.

MU reported third-quarter revenue of $41.46 billion, compared with $9.3 billion in the same period a year earlier.

The result exceeded analysts' expectations.

Adjusted earnings reached $25.11 per share on revenue of $41.5 billion, representing a 346% year-on-year increase.

Adjusted gross margin stood at 85%, while adjusted operating margin reached 81%.

The company also projected revenue of around $50 billion for the current quarter, compared with $11.3 billion in the corresponding period last year.

Micron also said customers had committed $22 billion to secure future memory chip supply.

Following the earnings announcement on Wednesday, Micron's shares surged more than 15% in a single session.

The stock has gained approximately 863% over the past year.

The rally briefly pushed Micron ahead of Meta Platforms and close to Tesla in terms of market capitalisation on Thursday.

Micron's market value had peaked at $1.398 trillion on Thursday's session compared with Meta Platforms at $1.392 trillion.

Tesla stood at around $1.4 trillion.

Micron currently has a market capitalisation of $1.37 trillion.

The company first crossed the $1 trillion market valuation mark on May 26, joining a group of semiconductor companies benefiting from investor enthusiasm surrounding artificial intelligence infrastructure.

Micron said second-quarter revenue quadrupled as demand for memory chips continued to outpace supply.

The company described the market as being supported by a demand-driven chip shortage that it expects to continue beyond 2027, marking a change from earlier expectations that supply constraints would ease sooner.

Micron now has 16 long-term chip supply agreements in place.

Growth was primarily driven by the company's two data-centre business segments, which together generated $25 billion in revenue, up 415% from a year earlier.

The rally for memory stocks is back on, with Micron leading the way.

The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to suitable alternatives.

Occidental Petroleum (OXY - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this oil and gas exploration and production company have returned -10.7% over the past month versus the Zacks S&P 500 composite's -1.4% change. The Zacks Oil and Gas - Integrated - United States industry, to which Occidental belongs, has lost 11.1% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Occidental is expected to post earnings of $1.89 per share, indicating a change of +384.6% from the year-ago quarter. The Zacks Consensus Estimate has changed +24.7% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $5.79 points to a change of +162% from the prior year. Over the last 30 days, this estimate has changed +8.5%.

For the next fiscal year, the consensus earnings estimate of $4.29 indicates a change of -25.8% from what Occidental is expected to report a year ago. Over the past month, the estimate has changed +17.9%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Occidental is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Occidental, the consensus sales estimate of $7.23 billion for the current quarter points to a year-over-year change of +12%. The $26.35 billion and $24.47 billion estimates for the current and next fiscal years indicate changes of +3.6% and -7.1%, respectively.

Last Reported Results and Surprise HistoryOccidental reported revenues of $5.11 billion in the last reported quarter, representing a year-over-year change of -25.3%. EPS of $1.06 for the same period compares with $0.87 a year ago.

Compared to the Zacks Consensus Estimate of $5.5 billion, the reported revenues represent a surprise of -7.03%. The EPS surprise was +63.08%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Occidental is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Occidental. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Key Takeaways Abbott faces Diagnostics weakness, China uncertainty and EPS dilution from the Exact Sciences deal.DXCM is expanding CGM adoption through new products, broader coverage and global market growth.DXCM reiterated 2026 revenue growth guidance of 11%-13% and expects wider G7 15 Day adoption. With the rising prevalence of diabetes worldwide, the demand for more efficient and real-time glucose monitoring solutions has intensified. Abbott (ABT - Free Report) and DexCom (DXCM - Free Report) are among the leading players in the continuous glucose monitoring (CGM) device market, valued at $13.4 billion in 2025 by Grand View Research.

Healthcare giant Abbott’s businesses span cardiovascular care, diagnostic testing, nutrition, pain and movement disorders, with Diabetes Care being a consistent top-line driver for the past several quarters. On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 diabetes using insulin therapy, as well as certain non-insulin users who struggle with hypoglycemia.

Here’s a closer look at both companies to determine which stock offers the more compelling investment opportunity today. 

The Case for Abbott

Abbott’s flagship, sensor-based CGM system, FreeStyle Libre, has quickly established global leadership across both Type 1 and Type 2 diabetes. CGM sales reached $2 billion in the first quarter of 2026, up 7.5% year over year, though growth was affected by a delay in an international tender renewal and a difficult prior-year comparison tied to shelf restocking dynamics. CGM growth is forecasted to return to double-digits in the second quarter.

Abbott’s CEO also remains bullish on the long-term CGM opportunity, estimating that 70-80 million people globally should be using CGMs compared with the current market of roughly 10-12 million users. Recently, the company secured CE Mark for the first-ever dual glucose-ketone sensing technology for people with diabetes, branded as Libre Duo and Libre Duo 10 Day.  The systems continuously measure glucose and ketone levels every minute and will integrate with the Libre digital health ecosystem.

Beyond Diabetes Care, Abbott’s Core Lab Diagnostics business is seeing robust demand across the United States, Europe and Latin America. However, Core Lab trends were flat in China, with the company continuing to expect a weaker market for the full year despite lapping prior pricing actions.

The March 2026 acquisition of Exact Sciences added a Cancer Diagnostics business, expanding presence in one of the fastest-growing areas of healthcare. Even so, the deal introduces a $0.20 dilution to the 2026 adjusted EPS guidance of $5.38 to $5.58.

Abbott’s Rapid and Molecular Diagnostics business suffered from lower demand for respiratory virus testing due to a much weaker respiratory season compared to last year. Management is taking a cautious view and is not assuming the shortfall will recover later in the year. The Established Pharmaceuticals Division benefits from branded generics positions in faster-growing geographies. Abbott is focused on restoring a healthier balance between price and volume over time in Nutrition, while its Medical Devices segment is gaining from scale advantages and new product cycles across the franchises.

Take a look at how analysts are projecting Abbott’s bottom line.

Image Source: Zacks Investment Research

The Case for DexCom

DexCom is benefitting from broader access to its CGM product portfolio, continued active base growth and new product launches. The company has partnered with several insulin delivery systems manufacturers to integrate its CGM products, with more than one million CGM users now connected to an automated insulin delivery (AID) system worldwide.

Internationally, DexCom’s 2026 first-quarter growth was widespread across core markets, with notable strong performance in countries such as France and Canada, where access has recently expanded. Management outlined a targeted international strategy aimed at gaining share through reimbursement progress and a portfolio tailored to local channels, including DexCom One+ in Europe. 

In the quarter, DexCom made an expanded rollout of the G7 15 Day sensor across all U.S. channels. The platform is now available with all U.S. pump partners, helping minimize friction for AID users who upgrade within the installed base. DexCom expects nearly 50% conversion of the U.S. base to the 15-day sensor by year-end 2026, with an international launch expected to begin in the second half of the year. The company also introduced its next-generation G8 roadmap, designed to deliver a step-change improvement in glucose performance with a smaller form factor and self-adapting sensor.

DexCom continues to build out its software ecosystem, adding engagement tools for Stelo, including enhanced Smart Meal Logging features, and it has been expanding provider-facing capabilities through Direct EHR Integration. More than 320 health systems have already integrated or are in the process of onboarding this capability across the United States and international markets. 

The company also continues to expand insurance coverage for its CGM sensors, particularly among Type 2 diabetes patients. The three largest U.S. Pharmacy Benefit Managers now cover DexCom CGM for all people with diabetes, including those with type 2 not using insulin. 

ABT also reiterated its 2026 revenue guidance, calling for 11% to 13% growth over 2025 levels. Take a look below at how the company’s earnings estimates are shaping up. 

Image Source: Zacks Investment Research

ABT & DXCM: Price Performance and Valuation

Year to date, ABT shares have declined 25.6%, whereas DexCom shares have climbed 4.1%.

Image Source: Zacks Investment Research

Abbott is trading at a forward, five-year Price/Sales (P/S) of 2.99X, below its median of 4.63X. Meanwhile, DXCM sits with a five-year P/S of 4.88X, also lower than its median of 9.93X.

Image Source: Zacks Investment Research

Conclusion

Both companies are poised to benefit from the long-term growth trends of the CGM market. However, Abbott continues to face respiratory testing volatility in Diagnostics, dilution risk following the Exact Sciences acquisition and ongoing uncertainty in China. DexCom is gaining from elevated CGM demand worldwide, new product launches and expanding coverage for its sensors.

While DexCom trades at a premium to Abbott, it remains well below its historical median. The stock has also delivered stronger YTD performance relative to Abbott. Coupled with positive earnings estimate revisions, existing DXCM holders may find it prudent to stay invested to enjoy growth prospects. Meanwhile, those holding ABT stock may find it wise to sell for now until the short-term operating visibility improves.

DXCM carries a Zacks Rank #3 (Hold), while ABT has a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The tech sector has been under some pressure recently, and one stock that has been hit hard is Broadcom (AVGO 2.52%). After hitting a record high of $495 in early June, the stock has now lost more than 22% of its value.

The stock took an initial hit following its fiscal Q2 earnings results, as it failed to lift its fiscal 2027 guidance for AI chip revenue. This seemed to be a clear overreaction, as there was no real reason for Broadcom management to raise a forecast more than a year away. The company is still projecting that its AI chip revenue will grow to well over $100 billion in fiscal 2027, a huge number given that it produced under $64 billion in fiscal 2025 revenue.

Image source: The Motley Fool.

Time to buy the dip on Broadcom The sell-off in Broadcom stock has brought its valuation down to a forward price-to-earnings (P/E) ratio of around 19.5 times fiscal 2027 analyst estimates. That's cheap for a stock that is riding two powerful market trends set to see explosive growth in the coming years.

The first trend Broadcom is riding is hyperscalers (owners of large data centers) looking to replace Nvidia's graphics processing units (GPUs) with cheaper alternatives for their AI workloads, especially for inference, which is an ongoing cost. The company is a leader in ASIC (application-specific integrated circuit) technology and helped Alphabet develop its highly successful Tensor Processing Units (TPUs). Alphabet plans to spend up to $190 billion in capital expenditures (capex) this year, with further increases next year, and much of that spending will go toward TPUs.

It has also allowed Anthropic to place TPU orders directly with Broadcom, including $21 billion worth to be delivered this year. The three companies recently extended their partnership for future TPU iterations.

The success of TPUs has also led other hyperscalers, including OpenAI, to begin developing their own custom AI chips with Broadcom's help. The company's list of AI ASIC customers is growing, and between its TPU business and new customers, this business is set to see strong growth in the coming years.

Today's Change

(

-2.52

%) $

-9.56

Current Price

$

369.35

At the same time, Broadcom is a leader in data center networking and co-packaged optics (CPO), two areas becoming increasingly important as AI cluster sizes continue to grow. Larger clusters require faster connectivity, making networking a critical component of overall system performance. This complements Broadcom's growing custom AI ASIC business, as customers often need both AI chips and networking solutions simultaneously. Broadcom's expertise in CPO could also provide an additional competitive advantage over time as hyperscalers seek to address power and bandwidth constraints.

Given its strong growth prospects and attractive valuation, I'd be buying this AI stock on this dip.

Shares of Rockwell Automation (ROK - Free Report) have been strong performers lately, with the stock up 5.4% over the past month. The stock hit a new 52-week high of $486.47 in the previous session. Rockwell Automation has gained 23.2% since the start of the year compared to the 14.2% move for the Zacks Computer and Technology sector and the 80% return for the Zacks Electronics - Miscellaneous Products industry.

What's Driving the Outperformance?The stock has a great record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on May 5, 2026, Rockwell Automation reported EPS of $3.3 versus consensus estimate of $2.89.

For the current fiscal year, Rockwell Automation is expected to post earnings of $12.95 per share on $8.97 in revenues. This represents a 22.98% change in EPS on a 7.52% change in revenues. For the next fiscal year, the company is expected to earn $14.53 per share on $9.46 in revenues. This represents a year-over-year change of 12.21% and 5.51%, respectively.

Valuation MetricsThough Rockwell Automation has recently hit a 52-week high, what is next for Rockwell Automation? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.

On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.

Rockwell Automation has a Value Score of D. The stock's Growth and Momentum Scores are B and A, respectively, giving the company a VGM Score of B.

In terms of its value breakdown, the stock currently trades at 37X current fiscal year EPS estimates, which is a premium to the peer industry average of 29.5X. On a trailing cash flow basis, the stock currently trades at 30.9X versus its peer group's average of 21X. Additionally, the stock has a PEG ratio of 3.08. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.

Zacks RankWe also need to look at the Zacks Rank for the stock, as this is even more important than the company's VGM Score. Fortunately, Rockwell Automation currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.

Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Rockwell Automation meets the list of requirements. Thus, it seems as though Rockwell Automation shares could have a bit more room to run in the near term.